- Trump administration's FY2026 budget proposal seeks 23% reduction in domestic spending.
- Key agencies like NOAA, State Department, and public broadcasting face significant cuts.
- Budget comes amid urgent appropriations talks, with House Republicans warning of potential shutdown risks.
Sharp Reductions in Domestic Spending
The Trump administration is preparing to unveil its fiscal year 2026 budget proposal today, with preliminary documents showing a 23% reduction in non-defense discretionary spending. The so-called "skinny budget" outline aligns with earlier reports of a 22.6% cut to domestic programs, targeting everything from climate research to international aid.
Specific reductions would hit NOAA particularly hard, with a proposed 25% budget slash that would eliminate its Office of Oceanic and Atmospheric Research. "These cuts would be devastating to our ability to improve severe weather forecasts," said one NOAA official who requested anonymity because they weren't authorized to speak publicly. Similar reductions are planned for State Department operations and public broadcasting entities like NPR and PBS.
Legislative Tightrope Walk
The proposal arrives as House Appropriations Chair Tom Cole (R-Okla.) pushes to advance spending bills before August. "You're looking at a government shutdown if we can't move these bills," Cole warned recently. The administration has also requested $9.3 billion in rescissions of previously approved funds, triggering a 45-day congressional review clock.
Meanwhile, the White House is separately pushing to make the 2017 tax cuts permanent—a move that would reduce federal revenue by an estimated $4.5 trillion over the next decade. Budget reconciliation may provide a path forward for both the tax extensions and spending reductions, though the scale of proposed cuts has drawn sharp criticism from research institutions and climate scientists.
University groups and medical researchers warn the reductions would jeopardize critical studies, including clinical trials for cancer and Alzheimer's treatments. As one NIH-affiliated researcher put it: "This isn't just about budgets—it's about whether breakthrough treatments reach patients who need them." The administration has not yet responded to requests for comment on these concerns.